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ABSTRACT 
This study was conducted to reveal the role of systemic low-grade inflammation by calculating the 
Neutrophil/Lymphocyte Ratio (NLR) in Vitreomacular Traction Syndrome (VMTS) of different etiologies. A retrospective 
examination was made of the medical records at a tertiary referral hospital. The study included 31 patients with diabetic 
VMTS, 27 patients with idiopathic VMTS, and 35 healthy subjects as the control group. The White Blood Cell (WBC) 
counts and Neutrophil-to-Lymphocyte Ratio (NLR) was compared. There were  insignificant differences between the 
groups in terms of mean age and female/male ratio (P>0.05). The mean  Standard Deviation (SD) of NLR was calculated 
as 2.43  0.83 in the diabetic VMTS group, 2.38  0.96 in the idiopathic VMTS group, and 1.83  0.52 in the control group 
(P=0.007). The values of the diabetic and idiopathic VMTS groups were significantly higher than those of the control 
group (P=0.002 and P=0.032, respectively). However, differences between the diabetic and idiopathic VMTS groups were 
insignificant (P=0.651). This study found significantly higher NLR in patients with diabetic and idiopathic VMTS than the 
control group. Elevated NLR could therefore be a potential indicator of VMTS, irrespective of the etiology. 
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INTRODUCTION
Anomaly in Posterior Vitreous Detachment (PVD) has 
been considered as an significant factor in the 
pathogenesis of vitreomacular interface. The progression 
of PVD can cause traction on the macula. Traction on the 
retina can lead to anatomic alterations in the 
vitreomacular interface and subsequently results in loss 
of vision [1]. If the vitreous is separated from the 
peripheral retina yet remains adherent posteriorly and 
causes an anteroposterior traction region encompassing 
the macular area, then Vitreomacular Traction Syndrome 
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(VMTS) occurs [2]. With the use of Optical Coherence 
Tomography (OCT), anteroposterior tractional force has 
been implicated as a reasonable cause of VMTS [3]. This 
traction can occur as idiopathic or may be related to 
retinal vascular diseases, posterior segment 
inflammatory diseases, trauma, surgery, retinal break, 
intraocular tumor, and miscellaneous ocular diseases. 
However, in diabetic retinopathy, VMTS can be a specific 
feature in presentation and management [4, 5]. The 
pigmented or non-pigmented cells of the ciliary body, 
retinal pigment epithelium cells, vascular system’s 
mesodermal elements, inflammatory or normal cells 
within the vitreous, or retinal glial cells consist of these 
tractional membranes and, stimulated in part by the 
inflammation. Those membranes are architecturally 
enhanced by the presence of fibrocytes and 
macrophages [6]. 
The evaluation of White Blood Cell (WBC) count, 
subtypes, and the calculation of their ratios to each other 
are useful markers of subclinical systemic inflammation 
[7]. The superiority of Neutrophil-to-Lymphocyte Ratio 
(NLR) to total leukocyte count has been shown in 
previous studies [8, 9]. The role of NLR in some systemic 
diseases has been reported, yet there has not yet been 
sufficient clarification of its relationship with ocular 
diseases [10-13].  
To the best of the author’s knowledge, the association of 
NLR and VMTS has never been reported. This study 
aimed at revealing the role of systemic low-grade 
inflammation by calculating NLR in VMTS of different 
etiologies.  
METHODS 
This study was conducted by the ophthalmology 
department at a tertiary referral hospital. Approval for 
the study was decided by the institutional review board 
and ethics committee. All procedures were accomplished 
in line with the ethical standards of the Helsinki 
Declaration for human subjects. A retrospective 
evaluation was made of the medical records of patients, 
who underwent pars plana vitrectomy due to VMTS 
between 2013 and 2017. The preoperative records 
included medical history, ocular or systemic medication, 
detailed ocular examination and routine laboratory 
results, including WBC. Only patients with diabetic and 
idiopathic VMTS were meticulously selected and included 
in the study. Coexistence of additional ocular 
pathologies, such as retinal vascular diseases, retinal 
break, intraocular tumor, chronic ocular medication, the 
history of uveitis, retinal surgery, and ocular trauma are 
considered as exclusion criteria. Patients with 
hematological disorders, malignancy, acute or chronic 
infection, other inflammatory ocular and systemic 
diseases, a history of steroid use, or any ocular 
medication were also excluded. All diabetic patients with 
VMTS (diabetic VMTS group, n=31) had stages of diabetic 
retinopathy and other patients (idiopathic VMTS group, 
n=27) with no risk factor related to VMTS were included. 
The control group (n=35) was established from random 
selection of healthy subjects hospitalized for cataract 
surgery with no history of any ocular (except senile 
cataract) or systemic diseases (including diabetes 
mellitus). All the records of the participants, from which 
the information was extracted were coded, and without 
informing the patient's name, the required information 
was extracted and used for final analysis. Vitreomacular 
traction syndrome was diagnosed using a spectral 
domain OCT (Heidelberg Engineering, Heidelberg, 
Germany), according to the criteria of the OCT-based 
definition of VMTS by the International Vitreomacular 
Traction Study Group [2]. To confirm the VMT in an eye, 
all of the following anatomical criteria were observed in 
at least one B-mode OCT scan, which included: 1. 
existence of sign of perifoveal vitreous cortex 
detachment from the retinal surface; 2. macular 
attachment of the vitreous cortex in the range of three 
millimeters radius of the fovea; and 3. accompaniment 
attachment with distortion of the surface of the fovea, 
changes in the structure of the intra-retina, bulging of 
fovea above the retinal pigment epithelium, or a 
combination of them without interrupting the entire 
thickness of all retinal layers. 
For all the study subjects evaluated with Horiba ABX 
Pentra 120 (Holliston, MA, USA), the neutrophil, 
lymphocyte, monocyte, platelet counts, and main 
platelet volume (MPV) values were retrieved from the 
hospital medical records. Neutrophil-to-lymphocyte, 
monocyte-to-lymphocyte, platelet-to-lymphocyte, and 
MPV-to-lymphocyte ratios were calculated by dividing 
the neutrophil, monocyte, platelet, and MPV counts by 
the lymphocyte count, respectively.  
Statistical analyses were performed using Statistical 
Package for the Social Sciences (SPSS) 24.0 software (IBM 
Corp, New York, USA). The mean age and female-to-male 
ratio of the groups were provided as descriptive data. 
The mean counts of WBC and calculations of defined 
variables were presented in tables. The fitting of 
numerical data to normal distribution was assessed by 
the Kolmogorov-Smirnov test. The non-parametric 
Kruskal-Wallis H test was applied to compare three 
independent samples when numerical data had not 
normal distribution. After Bonferroni correction, a P 
value of ≤0.05 was considered statistically significant. The 
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Mann-Whitney U test was used for post-hoc analysis of 
two independent samples and a P value of ≤0.05 was 
considered statistically significant. Receiver Operating 
Characteristics Curve (ROC) analysis was performed to 
determine the sensitivity and specificity of admission of 
NLR and the optimal cut-off value for predicting VMTS 
(irrespective of the etiology of the VMTS). 
RESULTS 
The mean and Standard Deviation (SD) for age of patients 
was 67.16  7.07 years in the diabetic VMTS group, 71.24 
 12.33 years in the idiopathic VMTS group, and 69.08  
8.42 years in the control group (P=0.253). The diabetic 
VMTS group comprised of 16 females and 15 males, the 
idiopathic VMTS group included 13 females and 14 
males, and the control group had 17 females and 18 
males (P = 0.727).  
The neutrophil, leukocyte, monocyte, platelet counts, 
and MPV values were similar in the three groups (all P 
values > 0.017). The meanSD of Neutrophil-to-
Lymphocyte Ratio was calculated as 2.43  0.83 in 
diabetic VMTS, 2.38  0.96 in idiopathic VMTS, and 1.83 
 0.52 in the control group. There was a significant 
difference between the three groups regarding the NLR 
(P=0.007). In the post-hoc analysis, the values of the 
diabetic and idiopathic VMTS groups were significantly 
higher than those of the control group (P=0.002 in 
diabetic VMTS versus control, and P=0.032 in idiopathic 
VMTS versus control), yet there was insignificant 
difference between the diabetic and idiopathic VMTS 
groups (P = 0.651). The monocyte-to-lymphocyte, 
platelet-to-lymphocyte, and MPV-to-lymphocyte ratios 
were also similar in the three groups (P>0.017). The 
results of the comparisons of the mean WBC counts and 
the calculations of defined variables are shown in Table 
1. In the ROC analysis, the area under the curve for NLR 
was 0.724, and an NLR of 2.01 or higher predicted VMTS 
(irrespective of the etiology of the VMTS) with a 
sensitivity of 62%, and specificity 84% (Fig 1). 
 
Table 1: The comparison of the WBC counts and calculations of the defined variables of diabetic VMTS (n=31), idiopathic VMTS (n=27), and control 
(n=35) groups. 
 Diabetic VMTS  
Mean  SD 
Idiopathic VMTS  
Mean  SD 
Control  
Mean  SD 
P value 
Neutrophil count (x103L) 4.48  1.46 3.95  1.08 3.96  1.00 0.407 
Lymphocyte count (x103L) 1.94  0.59 1.84  0.76 2.26  0.65 0.067 
Monocyte count (x103L) 0.40  0.33 0.31  0.15 0.41  0.18 0.157 
Platelet count (x103L) 247.65  89.55 232.41  61.44 227.92  50.70 0.533 
Mean platelet volume (MPV)(fL) 8.23  1.16 8.07  1.30 8.01  0.89 0.751 
Neutrophil-to-lymphocyte ratio 2.43  0.83 2.38  0.96 1.83  0.52 0.007* 
Monocyte-to-lymphocyte ratio 0.20  0.19 0.18  0.08 0.23  0.14 0.138 
Platelet-to-lymphocyte ratio 122.35  46.29 144.88  68.85 128.48  46.11 0.593 
Main platelet volume-to-lymphocyte ratio 4.27  1.37 5.04  1.99 4.77  2.47 0.318 
WBC: White blood cell; VMTS: Vitreomacular traction syndrome; SD: standard deviation; L: microliter; fL: femtolitre; n: number. 
* P=0.002 in diabetic VMTS vs. control, and P=0.032 in idiopathic VMTS vs. Control. P values less than 0.05. 
DISCUSSION
Aging is the main trigger of vitreous degeneration and 
PVD is the inevitable result of this condition in humans. 
The vitreous body shrinks with syneresis and the 
posterior hyaloid membrane becomes separated from 
the internal limiting membrane of retina. Posterior 
vitreous detachment consists of a number of phases 
occurring in a specific order. This physiological process 
can be affected negatively by several disorders, such as 
inflammation, trauma, and tumor, which result in the 
formation of anteroposterior and tangential contractile 
forces. Through different etiologies, astrocytes, 
myofibroblasts, and fibrocytes are known to play a key 
role in the occurrence of contraction in VMTS, yet the 
primary triggering mechanism of this process remains 
unclear [14, 15]. Takahashi et al. [16] revealed that the 
levels of numerous inflammatory cytokines are affected 
by the presence of PVD. These findings suggest that for 
various reasons, low-grade inflammation can cause 
VMTS. 
Recent studies have emphasized that NLR is the new 
indicator of inflammatory activity related to several 
ocular diseases. Kurtul et al. [17] reported NLR to be a 
simple, inexpensive, and reliable prognostic biomarker of 
age-related macular degeneration. Ozgonul et al. [18] 
stated that NLR can be used as a novel biomarker in 
primary open-angle glaucoma and Li et al. [19] reported 
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the diagnostic value of WBC counts in patients with 
primary angle-closure glaucoma. Dursun et al. [20] 
suggested that the optimal cut-off value of NLR was 1.89 
with 72.5% sensitivity and 100% specificity to predict 
retinal vein occlusion. These reports revealed the 
diagnostic value of NLR and the critical roles of 
inflammatory cascades in the pathophysiology of these 
diseases. In the current study, it was found that a higher 
value of NLR than the cut-off value has prognostic 




Figure 1:  The area under the Receiver Operating Characteristics (ROC) Curve. In the ROC Analysis, the area under the curve for Neutrophil-to-
Lymphocyte Ratio (NLR) was 0.724 and an NLR of 2.01 or higher predicted Vitreomacular Traction Syndrome  (VMTS), İrrespective of the etiology with a 
sensitivity of 62% and specificity 84% (P-value= 0.02; 95% confidence interval 0.604 – 0.844). 
Many epidemiological studies have reported that 
diabetes mellitus is associated with chronic inflammation 
[21, 22]. According to a study by Ulu et al., [23] NLR is a 
quick and reliable predictor of the severity of the diabetic 
retinopathy. They found a significantly higher NLR in 
patients with diabetic retinopathy compared with those 
without diabetic retinopathy [23]. The results of the 
current study supported the mentioned study in the 
sense that NLR was significantly higher in patients with 
diabetic VMTS, consistent with the inflammatory 
pathogenesis. Moreover, NLR was also determined to be 
higher in idiopathic VMTS.  
Currently, the pathogenesis of idiopathic VMTS is not 
completely clear. Low-grade inflammation can be 
considered to trigger the presence of VMTS, independent 
of whether the patient is diabetic.  
The spontaneous detachment of vitreomacular traction 
depends on the dimensions of adhesion, the width of the 
vitreomacular angle, the treatment of simultaneous 
disease of the retina with intravitreal injections, and the 
vitreomacular interface area values [24-26]. Another 
important treatment in VMTS is the injection of 
ocriplasmin [27]. However, if both patient observation 
and medical treatment are unsuccessful or undesirable, 
pars plana vitrectomy is currently considered as the main 
treatment of the idiopathic VMTS [28]. There is ongoing 
research on the potential use of anti-inflammatory drugs 
in the treatment of several retinal diseases, such as age-
related macular degeneration [29]. Understanding the 
pathogenesis of idiopathic VMTS brings new perspectives 
to treatment of the disease. It can be speculated that the 
development of medical anti-inflammatory treatment for 
idiopathic VMTS could replace pars plana vitrectomy. 
To the best of the author’s knowledge, this is the first 
study investigating the relationship between NLR and 
VMTS. There were a number of limitations in this study. 
First, the sample size of the study was relatively small. 
Second, the data were not multicenter and the study 
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design was retrospective case-control. Third, this study 
was not suitable for assessment of other potentially 
relevant factors, because the controls were healthy and 
did not have any systemic or ocular disease except 
cataract.  
CONCLUSION 
The results of this study demonstrate that NLR was 
significantly higher in diabetic and idiopathic VMTS than 
in healthy subjects. Elevated NLR can therefore be 
considered a potential indicator of VMTS, irrespective of 
the etiology. These results suggest that systemic low-
grade inflammation plays a role in the development of 
diabetic or idiopathic VMTS.  
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